1. Home
  2. CTMX vs WW Comparison

CTMX vs WW Comparison

Compare CTMX & WW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • WW
  • Stock Information
  • Founded
  • CTMX 2008
  • WW 1961
  • Country
  • CTMX United States
  • WW United States
  • Employees
  • CTMX N/A
  • WW N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • WW Other Consumer Services
  • Sector
  • CTMX Health Care
  • WW Consumer Discretionary
  • Exchange
  • CTMX Nasdaq
  • WW Nasdaq
  • Market Cap
  • CTMX 85.3M
  • WW 75.9M
  • IPO Year
  • CTMX 2015
  • WW 2001
  • Fundamental
  • Price
  • CTMX $0.84
  • WW $1.21
  • Analyst Decision
  • CTMX Buy
  • WW Buy
  • Analyst Count
  • CTMX 6
  • WW 5
  • Target Price
  • CTMX $5.77
  • WW $3.44
  • AVG Volume (30 Days)
  • CTMX 1.2M
  • WW 3.7M
  • Earning Date
  • CTMX 03-10-2025
  • WW 02-26-2025
  • Dividend Yield
  • CTMX N/A
  • WW N/A
  • EPS Growth
  • CTMX N/A
  • WW N/A
  • EPS
  • CTMX 0.16
  • WW N/A
  • Revenue
  • CTMX $126,617,000.00
  • WW $807,465,000.00
  • Revenue This Year
  • CTMX $22.55
  • WW N/A
  • Revenue Next Year
  • CTMX N/A
  • WW N/A
  • P/E Ratio
  • CTMX $5.20
  • WW N/A
  • Revenue Growth
  • CTMX 33.66
  • WW N/A
  • 52 Week Low
  • CTMX $0.79
  • WW $0.67
  • 52 Week High
  • CTMX $5.85
  • WW $5.22
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 33.95
  • WW 44.34
  • Support Level
  • CTMX $0.79
  • WW $1.17
  • Resistance Level
  • CTMX $1.17
  • WW $1.86
  • Average True Range (ATR)
  • CTMX 0.08
  • WW 0.14
  • MACD
  • CTMX -0.03
  • WW -0.04
  • Stochastic Oscillator
  • CTMX 13.16
  • WW 6.43

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About WW WW International Inc.

WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.

Share on Social Networks: